Anthraquinone Pharmaceutical Intermediate from Japan
Synthetic anthraquinone used as a key intermediate in producing anthracycline chemotherapy drugs like doxorubicin. It qualifies for HTS 2914.69.21.00 as a quinone 'drug' under Chapter 29 due to its specific pharmaceutical application and chemical definition.
Duty Rate — Japan → United States
22%
Rate breakdown
9903.04.629.5%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.4912.5%Except for products described in headings 9903.05.85–9903.05.92, articles the product of Japan, with an ad valorem (or ad valorem equivalent) rate of duty under column 1 less than 12.5 percent, as provided for in U.S. note 52 to this subchapter
Import Tips
• Include end-user letters from pharma manufacturers proving drug synthesis use to secure 'drugs' classification
• High purity (>99%) required; test certificates must specify absence of isomers per Chapter 29 note (b)